Next-Generation Insufflation System with Advanced Filter Technologies and AI-Powered Gas Flow Control

Publication ID: 24-11857719_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Insufflation System with Advanced Filter Technologies and AI-Powered Gas Flow Control,” Published Technical Disclosure No. 24-11857719_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857719_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,719.

Summary of the Inventive Concept

A paradigm-shifting insufflation system incorporating advanced nanofiltration, antimicrobial technologies, and AI-powered gas flow control to revolutionize medical gas delivery and patient care.

Background and Problem Solved

The original filter assembly patent addressed the need for effective medical gas filtration in insufflation systems. However, the existing design has limitations in terms of filter medium effectiveness, gas flow control, and patient interface. The new inventive concept addresses these limitations by introducing advanced filter technologies, AI-powered gas flow control, and real-time bio-sensing feedback to enhance patient outcomes.

Detailed Description of the Inventive Concept

The next-generation insufflation system features a modular, multi-stage filter assembly incorporating advanced nanofiltration and antimicrobial technologies to ensure ultra-pure medical gas delivery. The system is controlled by a self-calibrating, AI-powered gas flow controller that dynamically adjusts gas properties in real-time based on patient-specific physiological data. The patient interface features real-time, bio-sensing feedback to optimize gas composition, temperature, and humidity for enhanced patient outcomes. Additionally, the system includes a hybrid, electrostatic-mechanical filter medium, a compact, spiral-shaped housing, and an integrated, micro-sensor array for real-time gas quality monitoring.

Novelty and Inventive Step

The new claims introduce a paradigm shift in insufflation technology by incorporating AI-powered gas flow control, real-time bio-sensing feedback, and advanced filter technologies. These innovations overcome the limitations of the original patent and provide a significant improvement in medical gas delivery and patient care.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include variations in filter medium design, gas flow controller algorithms, and patient interface configurations to accommodate different medical applications and patient needs. Additionally, the system could be adapted for use in other medical devices, such as ventilators or anesthetic machines.

Potential Commercial Applications and Market

The next-generation insufflation system has significant commercial potential in the medical device industry, particularly in the areas of laparoscopic surgery, cardiac surgery, and patient care. The system's advanced features and improved patient outcomes could position it as a market leader, with potential applications in hospitals, clinics, and other healthcare facilities.

CPC Classifications

SectionClassGroup
A A61 A61M13/003
A A61 A61M16/0875
A A61 A61M16/106
A A61 A61M16/1095
A A61 A61M16/161
A A61 A61M2202/0225
A A61 A61M2205/3327
A A61 A61M2205/3331
A A61 A61M2205/3334
A A61 A61M2205/3368
A A61 A61M2205/3569
A A61 A61M2205/3653
A A61 A61M2205/7527
A A61 A61M2205/7536

Original Patent Information

Patent NumberUS 11,857,719
TitleFilter assembly
Assignee(s)Fisher & Paykel Healthcare Limited